Brielle Benyon

From Sam Neill announcing his cancer diagnosis to Martina Navratilova stating that she is now cancer-free, here’s what’s happening in the oncology space this week.

We recently asked our audience how they advocate for themselves and others in the oncology space. Here’s what they had to say.

Patients with HER2-positive breast cancer often need to undergo aggressive treatment, but ongoing research is determining if chemotherapy can be scaled back for certain patients.

A multiple myeloma survivor discusses how continued minimal residual disease negativity made her feel more confident in coming off of maintenance therapy.

The National Comprehensive Cancer Network updated their guidelines to state that Qinlock is the recommended second-line treatment for patients with Sutent-intolerant gastrointestinal stromal tumors.

Here’s a look back at the cancer drugs that gained FDA approval in the winter of 2023.

From Robin Roberts providing an update on her partner, Amber Laign’s “rough year” with breast cancer, to Kathy Griffin’s suspected cause of lung cancer, here’s what’s happening in the oncology space this week.

Earlier treatment with Jakafi showed promise in both improving survival and symptom burden in certain patients with myelofibrosis, though physicians often delay Jakafi treatment.

The Food and Drug Administration is reviewing remestemcel-L for the treatment of children with steroid-refractory acute graft-versus-host disease.

From a contestant on “Queer Eye” dying of cancer to a string of brain cancers in former Philadelphia Phillies players, here’s what’s happening in the oncology space this week.

A cervical cancer survivor tells her story of how a MLM company urged her to use her diagnosis to sell more products.

The Food and Drug Administration accepted a supplemental Biologics License Application for Opdivo to treat stage 2B or C, fully resected melanoma.

A nutritionist discussed the difference between mainstream diets and oncology nutrition, and how patients with cancer can ensure they’re on the right track to being well-nourished throughout cancer treatment.

Experts are concerned that the train derailment in Ohio may pose cancer risks down the line.

Long-term follow-up of Nubeqa for nonmetastatic castration-resistant prostate cancer showed that the drug was safe and effective in treating this patient population.

The first patient was enrolled in a three-drug clinical trial, which researchers hope will lend insight into immunotherapy resistance in lung cancer.

The drug duo Lenvina plus Keytruda led to improved outcomes for patients with advanced renal cell carcinoma, extended follow-up of the CLEAR trial showed.

Caregivers become increasingly important in medical decision-making for patients with dementia and cancer.

After a patient receives a kidney cancer diagnosis, there are some important conversations to have with their health care team.

Researchers are recruiting patients with ER-positive, HER2-negative breast cancer to participate in a trial evaluating (Z)-endoxifen.

From comedian Chris Tucker teaming up with a nonprofit to educate Black men on their prostate cancer risk to Leeane Hainby and Rep. Jamie Raskin providing updates on their cancer treatment, here’s what’s happening in the cancer space this week.

Karen Estrada was shocked when she was diagnosed with leukemia and ended up on a lifesaving clinical trial, although her journey was not entirely smooth.

Standard corticosteroid use may not be the best treatment for patients with cancer who experience immunotherapy-related heart issues, research showed.

An expert explains what patients with low-grade prostate cancer can expect when undergoing genomic testing — and why the procedure is important.

A clinical trial is currently enrolling patients who are experiencing hand-foot skin reaction as a result of kidney cancer treatment.

A clinical trial just kicked off, analyzing Padcev in patients with advanced, unresectable bladder cancer.

In honor of National Caregivers’ Day, CURE® took a look back at some of our most popular content from and about cancer caregivers.

From Senator Bob Casey undergoing prostate cancer surgery to a man giving away his Superbowl tickets to a good friend with stage 4 cancer, here’s what is happening in the oncology space this week.

The administration of Pluvicto within six months of radium-223 treatment proved to be safe and efficacious in patients with metastatic castration-resistant prostate cancer, research showed.

Teri Griege completed an Ironman triathlon in 2009, and less than a month later received a stage 4 colorectal cancer diagnosis. In this episode of Cancer Horizons, she shared her story.